Company Filing History:
Years Active: 2018-2025
Title: Hella Kohlhof: Innovator in Pharmaceutical Research
Introduction
Hella Kohlhof, located in Munich, Germany, is an accomplished inventor with a remarkable portfolio of eight patents. Her innovative contributions to pharmaceutical research focus on the treatment and prevention of viral diseases, positioning her as a significant influence in the medical field.
Latest Patents
Among her latest inventive achievements is the patent for Vidofludimus, a compound designed for the treatment or prevention of viral infections, particularly those caused by coronaviruses, including SARS-CoV-2 and its variants. This invention specifically targets the inhibition of dihydroorotate dehydrogenase (DHODH), a critical enzyme in cell metabolism that offers potential therapeutic options for viral diseases.
Another notable patent focuses on calcium salt polymorphs that act as anti-inflammatory, immunomodulatory, and anti-proliferative agents. This invention involves a specific white crystalline polymorph A of the calcium salt of a compound characterized by an X-ray powder diffraction pattern. These polymorphs are valuable due to their unique properties, which may enhance treatments for diseases that benefit from the inhibition of DHODH.
Career Highlights
Hella Kohlhof has worked with prominent companies such as Immunic AG and 4SC AG, where she has made substantial strides in pharmaceutical innovation. Her career reflects a dedicated pursuit of advancements in medical treatments, especially concerning viral infections and inflammatory diseases.
Collaborations
Throughout her career, Hella has collaborated with esteemed colleagues, including Daniel Vitt and Andreas Mühler. Their collective efforts have not only propelled her work forward but have also significantly contributed to the fields of pharmacology and biotechnology.
Conclusion
As an inventor, Hella Kohlhof exemplifies the spirit of innovation through her extensive research and development in pharmaceutical applications. Her latest works pave the way for new treatments against viral diseases, showcasing her commitment to improving healthcare outcomes. Her impactful patents reflect the ongoing evolution of medical science, driven by the dedication of inventors like Hella.